Europe’s €5bn scaleup fund will not fix biotech’s funding gap. Even its backers say so

EU PERSPECTIVES - Europe's top life sciences investors have welcomed the EU's new €5bn Scaleup Europe Fund. One of its own backers, Novo Holdings, has just put €500m into it. Yet the same investors told EU Perspectives the fund will barely touch their sector's real funding problem. Read more

Biotech's funding gap will not be solved in the lab — it is a Brussels problem too / Photo: Adam Bezer (Unsplash)